Common misdiagnoses in lymphomas and avoidance strategies.

[1]  R. Warnke,et al.  Anaplastic Large‐Cell Lymphoma , 2011 .

[2]  H. Kerl,et al.  Subcutaneous “Panniculitis‐Like” T‐Cell Lymphoma , 2010 .

[3]  R. Gascoyne,et al.  Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival. , 2009, Blood.

[4]  J. Chan,et al.  IgG4-related sclerosing pachymeningitis: a previously unrecognized form of central nervous system involvement in IgG4-related sclerosing disease. , 2009, American Journal of Surgical Pathology.

[5]  J. Chan,et al.  IgG4-related Sclerosing Mastitis: Description of a New Member of the IgG4-related Sclerosing Diseases , 2009, The American journal of surgical pathology.

[6]  M. Schinstine.  Kikuchi's lymphadenitis , 2009, Diagnostic cytopathology.

[7]  Shigeo Nakamura,et al.  Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance. , 2009, Blood.

[8]  C. Chen,et al.  CD3-positive Large B-cell Lymphoma , 2009, The American journal of surgical pathology.

[9]  H. Asaoku,et al.  Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease , 2009, Modern Pathology.

[10]  A. LaCasce,et al.  Comparison of referring and final pathology for patients with non-Hodgkin's lymphoma in the National Comprehensive Cancer Network. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  N. Harris,et al.  CD20+ T-cell Lymphoma: Clinicopathologic Analysis of 9 Cases and a Review of the Literature , 2008, The American journal of surgical pathology.

[12]  T. Falk,et al.  Pseudoclonality in cutaneous pseudolymphomas: a pitfall in interpretation of rearrangement studies , 2008, The British journal of dermatology.

[13]  P. Gaulard,et al.  Primary mediastinal (thymic) large B-cell lymphoma , 2008 .

[14]  J. Chan,et al.  Lymphadenopathy of IgG4-related Sclerosing Disease , 2008, The American journal of surgical pathology.

[15]  C. Massone,et al.  Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases. , 2008, Blood.

[16]  N. Shinton.  WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues , 2007 .

[17]  P. Gaulard,et al.  Histologic Evolution of Angioimmunoblastic T-cell Lymphoma in Consecutive Biopsies: Clinical Correlation and Insights Into Natural History and Disease Progression , 2007, The American journal of surgical pathology.

[18]  N. Harris,et al.  NK-cell lymphomas and leukemias: a spectrum of tumors with variable manifestations and immunophenotype. , 2007, American journal of clinical pathology.

[19]  B. Eyden,et al.  Aberrant leukocyte common antigen expression in metastatic small cell lung carcinoma: a rare finding and a potential diagnostic pitfall. , 2007, Applied immunohistochemistry & molecular morphology : AIMM.

[20]  J. Chan,et al.  Autoimmune Pancreatitis???Prototype of IgG4-related Sclerosing Disease , 2007 .

[21]  Y. Kwong.  Predicting the outcome in non‐Hodgkin lymphoma with molecular markers , 2007, British journal of haematology.

[22]  J. Chan,et al.  Chronic sclerosing dacryoadenitis: part of the spectrum of IgG4-related Sclerosing disease? , 2007, The American journal of surgical pathology.

[23]  T. Molina,et al.  Improved reliability of lymphoma diagnostics via PCR-based clonality testing: — Report of the BIOMED-2 Concerted Action BHM4-CT98-3936 , 2007, Leukemia.

[24]  T. Molina,et al.  Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936 , 2007, Leukemia.

[25]  T. Molina,et al.  Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936 , 2007, Leukemia.

[26]  T. Molina,et al.  Polymerase chain reaction-based clonality testing in tissue samples with reactive lymphoproliferations: usefulness and pitfalls. A report of the BIOMED-2 Concerted Action BMH4-CT98-3936 , 2007, Leukemia.

[27]  Richard Simon,et al.  Molecular diagnosis of Burkitt's lymphoma. , 2006, The New England journal of medicine.

[28]  R. Spang,et al.  A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. , 2006, The New England journal of medicine.

[29]  S. Pileri,et al.  Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  H. Bobby Gaspar,et al.  Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype , 2006, British journal of haematology.

[31]  Y. Kwong.  Natural killer-cell malignancies: diagnosis and treatment , 2005, Leukemia.

[32]  T. Habermann,et al.  Adult B-Cell Lymphomas With Burkitt-Like Morphology Are Phenotypically and Genotypically Heterogeneous With Aggressive Clinical Behavior , 2005, The American journal of surgical pathology.

[33]  H. Müller-Hermelink,et al.  Clinical, Immunophenotypic, and Genetic Analysis of Adult Lymphomas With Morphologic Features of Burkitt Lymphoma , 2005, The American journal of surgical pathology.

[34]  E. Jaffe,et al.  Histologic Features of Sinus Histiocytosis With Massive Lymphadenopathy in Patients With Autoimmune Lymphoproliferative Syndrome , 2005, The American journal of surgical pathology.

[35]  A. Rosenwald,et al.  Report: workshop on mediastinal grey zone lymphoma , 2005, European journal of haematology. Supplementum.

[36]  Y. Kwong,et al.  Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[37]  F. Rieux-Laucat,et al.  Autoimmune lymphoproliferative syndrome with somatic Fas mutations. , 2004, The New England journal of medicine.

[38]  T. Golub,et al.  The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. , 2003, Blood.

[39]  L. Staudt,et al.  Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma , 2003, The Journal of experimental medicine.

[40]  A. Dogan,et al.  Angioimmunoblastic T‐cell lymphoma , 2003, British journal of haematology.

[41]  J. Delabie,et al.  The Value of Anti-Pax-5 Immunostaining in Routinely Fixed and Paraffin-Embedded Sections: A Novel Pan Pre-B and B-Cell Marker , 2002, The American journal of surgical pathology.

[42]  C. Copie-Bergman,et al.  Pyothorax-Associated Lymphoma: A Peculiar Clinicopathologic Entity Derived From B Cells at Late Stage of Differentiation and With Occasional Aberrant Dual B- and T-Cell Phenotype , 2002, The American journal of surgical pathology.

[43]  B. Nathwani,et al.  Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[44]  P. Isaacson,et al.  Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. , 2002, Blood.

[45]  S. Pileri,et al.  Myeloperoxidase expression by histiocytes in Kikuchi's and Kikuchi-like lymphadenopathy. , 2001, The American journal of pathology.

[46]  E. Jaffe,et al.  Peripheral T-Cell Lymphoma with Aberrant Expression of CD79a and CD20: A Diagnostic Pitfall , 2001, Modern Pathology.

[47]  J. Chan,et al.  Hypocellular Anaplastic Large Cell Lymphoma Mimicking Inflammatory Lesions of Lymph Nodes , 2000, The American journal of surgical pathology.

[48]  M. Noguchi,et al.  Clonal Proliferation of B Lymphocytes in the Germinal Centers of Human Reactive Lymph Nodes: Possibility of Overdiagnosis of B Cell Clonal Proliferation , 2000, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[49]  W. Jurecka,et al.  Immunoreactivity of B-Cell Markers (CD79a, L26) in Rare Cases of Extranodal Cytotoxic Peripheral T- (NK/T-) Cell Lymphomas , 2000, Modern Pathology.

[50]  J. Chan.  The Perivascular Cuff of Large Lymphoid Cells: A Clue to Diagnosis of Anaplastic Large Cell Lymphoma , 2000, International journal of surgical pathology.

[51]  G. Lenz,et al.  Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin's disease provides further evidence for its B-cell origin. , 1999, Blood.

[52]  E. Jaffe,et al.  A biophenotypic human herpesvirus 8--associated primary bowel lymphoma. , 1999, The American journal of surgical pathology.

[53]  J. Chan.  Peripheral T-cell and NK-cell neoplasms: an integrated approach to diagnosis. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[54]  E. Jaffe,et al.  Pathological findings in human autoimmune lymphoproliferative syndrome. , 1998, The American journal of pathology.

[55]  J. Chan,et al.  Anaplastic Large Cell Lymphoma: Redefining Its Morphologic Spectrum and Importance of Recognition of the ALK‐Positive Subset , 1998, Advances in anatomic pathology.

[56]  B. Nathwani,et al.  A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin's lymphoma: a report of the Non-Hodgkin's Lymphoma Classification Project , 1997 .

[57]  E. Jaffe,et al.  Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. , 1997, Blood.

[58]  D. Huhn,et al.  Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. , 1997, Blood.

[59]  E. Jaffe,et al.  Immunodeficiency‐Associated Malignant Lymphoma: Three Cases Showing Genotypic Evidence of Both T‐ and B‐Cell Lineages , 1994, The American journal of surgical pathology.

[60]  T. Tedder,et al.  CD20: a regulator of cell-cycle progression of B lymphocytes. , 1994, Immunology today.

[61]  J. Chan,et al.  Kikuchi's Lymphadenitis: A Morphologic Analysis of 75 Cases with Special Reference to Unusual Features , 1994 .

[62]  B. Nathwani,et al.  Hodgkin's disease occurring in monocytoid B-cell clusters. , 1991, American journal of clinical pathology.

[63]  A. Norton,et al.  Antigen Preservation in Infarcted Lymphoid Tissue: A Novel Approach to the Infarcted Lymph Node Using Monoclonal Antibodies Effective in Routinely Processed Tissues , 1988, The American journal of surgical pathology.

[64]  F. Kuhajda,et al.  Common leukocyte antigen staining of a primitive sarcoma , 1987, Cancer.

[65]  D. Parham,et al.  Infectious Mononucleosis The Spectrum of Morphologic Changes Simulating Lymphoma in Lymph Nodes and Tonsils , 1987, The American journal of surgical pathology.

[66]  J. Davies,et al.  Lymph‐node infarction and malignant lymphoma: a multicentre survey of European, English and American cases , 1986, Histopathology.

[67]  D. Variakojis,et al.  The foamy macrophages in Hodgkin's disease. , 1972, Archives of pathology.